This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.
0
Mappings
0
Definitions
0
Inheritance
4
Pathophysiology
0
Histopathology
8
Phenotypes
12
Genes
5
Treatments
0
Subtypes
0
Differentials
0
Datasets
0
Trials
🏷

Classifications

Harrison's Chapter
digestive system disorder autoimmune disease

Pathophysiology

4
Gluten-Triggered Immune Response
Gluten peptides (gliadin) cross the intestinal epithelium and are deamidated by tissue transglutaminase (tTG). Deamidated peptides bind HLA-DQ2/DQ8 and activate CD4+ T cells.
T Helper Cell link
Antigen Processing link
Show evidence (3 references)
PMID:10684852 SUPPORT
"tissue transglutaminase (tTG)-mediated deamidation of gliadin plays an important role in recognition of this food antigen by intestinal T cells"
Demonstrates the critical role of tTG deamidation in converting gluten peptides into immunogenic epitopes recognized by T cells in celiac disease.
PMID:10684852 SUPPORT
"the deamidated peptides displayed an increased affinity for DQ2, a molecule known to preferentially bind peptides containing negatively charged residues"
Shows how tTG deamidation increases HLA-DQ2 binding affinity by introducing negatively charged glutamate residues, enhancing antigen presentation.
PMID:38914866 SUPPORT
"Transglutaminase 2 (TG2) plays a pivotal role in the pathogenesis of celiac disease (CeD) by deamidating dietary gluten peptides, which facilitates antigenic presentation and a strong anti-gluten T cell response."
Confirms TG2 deamidation as the pivotal mechanism enabling gluten peptide presentation and T cell activation in celiac disease pathogenesis.
Intestinal Epithelial Damage
Activated T cells release IFN-gamma and other cytokines causing villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes. Leads to malabsorption.
Intestinal Epithelial Cell link
Apoptosis link
Show evidence (4 references)
PMID:38914866 SUPPORT
"Nearly half of the gluten-induced gene expression changes in CeD were associated with the epithelial interferon-γ response."
Demonstrates that IFN-gamma signaling drives a major portion of the transcriptional changes underlying epithelial damage in celiac disease.
PMID:15357947 SUPPORT
"under conditions of dysregulated IL15 expression in vivo in patients with celiac disease and in vitro in healthy individuals, multiple steps of the NKG2D/DAP10 signaling pathway leading to ERK and JNK activation are coordinately primed to activate direct cytolytic function independent of TCR..."
Shows how IL-15 converts intraepithelial CD8+ T cells into cytotoxic lymphokine-activated killer cells via NKG2D signaling, mediating epithelial damage.
PMID:24942692 SUPPORT
"the upregulation of IL-15 expression in the intestinal mucosa has become a hallmark of the disease"
Identifies IL-15 upregulation as a defining feature of celiac disease that drives intraepithelial lymphocyte expansion and epithelial injury.
+ 1 more reference
Autoantibody Production
B cells produce antibodies against tTG (anti-tTG IgA) and deamidated gliadin peptides (anti-DGP). These serve as diagnostic markers and may contribute to pathology.
Plasma Cell link
Show evidence (1 reference)
PMID:39273359 NO_EVIDENCE
"Celiac disease (CD) is an immune-mediated enteropathy triggered by the ingestion of proline- and glutamine-rich proteins, widely termed "gluten", in genetically susceptible individuals. CD induces an altered immune response that leads to chronic inflammation and duodenal mucosal damage."
Describes the immune-mediated nature of celiac disease, which includes both cellular and humoral (antibody) responses to gluten antigens.
Barrier Dysfunction
Increased intestinal permeability allows greater gluten peptide translocation. Zonulin upregulation disrupts tight junctions.
Show evidence (1 reference)
PMID:38914866 PARTIAL
"ZED1227 treatment preserved transcriptome signatures associated with mucosal morphology, inflammation, cell differentiation and nutrient absorption to the level of the gluten-free diet group."
Blocking TG2 prevents gluten-induced disruption of epithelial barrier integrity and differentiation programs, indicating barrier dysfunction is downstream of adaptive immune activation.

Phenotypes

8
Blood 1
Iron Deficiency Anemia FREQUENT Anemia (HP:0001903)
From malabsorption
Show evidence (1 reference)
PMID:38914866 PARTIAL
"ZED1227 treatment preserved transcriptome signatures associated with mucosal morphology, inflammation, cell differentiation and nutrient absorption to the level of the gluten-free diet group."
Anemia results from malabsorption of iron and other nutrients due to villous atrophy and impaired epithelial absorptive function in damaged small intestine.
Digestive 2
Chronic Diarrhea FREQUENT Chronic diarrhea (HP:0002028)
Show evidence (1 reference)
PMID:39273359 PARTIAL
"CD induces an altered immune response that leads to chronic inflammation and duodenal mucosal damage."
Chronic inflammation and mucosal damage from immune response to gluten leads to malabsorption and chronic diarrhea as a cardinal symptom.
Bloating FREQUENT Abdominal distention (HP:0003270)
Immune 1
Dermatitis Herpetiformis OCCASIONAL Skin rash (HP:0000988)
Skin manifestation of celiac
Musculoskeletal 1
Osteoporosis OCCASIONAL Reduced bone mineral density (HP:0004349)
From calcium/vitamin D malabsorption
Constitutional 2
Abdominal Pain FREQUENT Abdominal pain (HP:0002027)
Fatigue FREQUENT Fatigue (HP:0012378)
Growth 1
Weight Loss FREQUENT Weight loss (HP:0001824)
Show evidence (1 reference)
PMID:38914866 PARTIAL
"ZED1227 treatment preserved transcriptome signatures associated with mucosal morphology, inflammation, cell differentiation and nutrient absorption to the level of the gluten-free diet group."
Weight loss results from impaired nutrient absorption due to villous atrophy and loss of epithelial cell differentiation and absorptive capacity.
🧬

Genetic Associations

12
HLA-DQ2 (Risk Factor)
HLA-DQ8 (Risk Factor)
IL2 (Risk Factor)
IL21 (Risk Factor)
BACH2 (GWAS)
TNFAIP3 (GWAS)
CD28 (GWAS)
EGR2 (GWAS)
ETS1 (GWAS)
IRF4 (GWAS)
SMAD3 (GWAS)
PTPN22 (GWAS)
💊

Treatments

5
Gluten-Free Diet
Lifelong strict gluten avoidance is the only effective treatment.
Nutritional Supplementation
Iron, calcium, vitamin D, B12 as needed.
Monitoring
Regular serology and bone density monitoring.
Corticosteroids
For refractory celiac disease.
Dietitian Counseling
Essential for dietary compliance.
🌍

Environmental Factors

4
Gluten Exposure
Required trigger
Early Gluten Introduction
Timing may affect risk
Gastrointestinal Infections
May trigger onset
Gut Microbiome
May modulate risk
🔬

Biochemical Markers

4
Anti-tTG IgA (Elevated)
Context: Primary diagnostic marker
Anti-Endomysial Antibodies (Elevated)
Context: Highly specific
Anti-DGP Antibodies (Elevated)
Context: Useful when IgA deficient
Total IgA (Variable)
Context: IgA deficiency common in celiac
{ }

Source YAML

click to show
name: Celiac Disease
creation_date: '2025-12-18T17:01:35Z'
updated_date: '2026-02-17T21:53:14Z'
category: Complex
parents:
- Gastrointestinal Disease
- Autoimmune Disease
disease_term:
  preferred_term: celiac disease
  term:
    id: MONDO:0005130
    label: celiac disease
pathophysiology:
- name: Gluten-Triggered Immune Response
  description: >
    Gluten peptides (gliadin) cross the intestinal epithelium and are
    deamidated by tissue transglutaminase (tTG). Deamidated peptides
    bind HLA-DQ2/DQ8 and activate CD4+ T cells.
  cell_types:
  - preferred_term: T Helper Cell
    term:
      id: CL:0000492
      label: CD4-positive helper T cell
  biological_processes:
  - preferred_term: Antigen Processing
    term:
      id: GO:0019882
      label: antigen processing and presentation
  evidence:
  - reference: PMID:10684852
    supports: SUPPORT
    snippet: "tissue transglutaminase (tTG)-mediated deamidation of gliadin plays
      an important role in recognition of this food antigen by intestinal T cells"
    explanation: Demonstrates the critical role of tTG deamidation in converting
      gluten peptides into immunogenic epitopes recognized by T cells in celiac
      disease.
  - reference: PMID:10684852
    supports: SUPPORT
    snippet: "the deamidated peptides displayed an increased affinity for DQ2, a molecule
      known to preferentially bind peptides containing negatively charged residues"
    explanation: Shows how tTG deamidation increases HLA-DQ2 binding affinity by
      introducing negatively charged glutamate residues, enhancing antigen
      presentation.
  - reference: PMID:38914866
    supports: SUPPORT
    snippet: "Transglutaminase 2 (TG2) plays a pivotal role in the pathogenesis of
      celiac disease (CeD) by deamidating dietary gluten peptides, which facilitates
      antigenic presentation and a strong anti-gluten T cell response."
    explanation: Confirms TG2 deamidation as the pivotal mechanism enabling
      gluten peptide presentation and T cell activation in celiac disease
      pathogenesis.
- name: Intestinal Epithelial Damage
  description: >
    Activated T cells release IFN-gamma and other cytokines causing
    villous atrophy, crypt hyperplasia, and increased intraepithelial
    lymphocytes. Leads to malabsorption.
  cell_types:
  - preferred_term: Intestinal Epithelial Cell
    term:
      id: CL:0002563
      label: intestinal epithelial cell
  biological_processes:
  - preferred_term: Apoptosis
    term:
      id: GO:0006915
      label: apoptotic process
  evidence:
  - reference: PMID:38914866
    supports: SUPPORT
    snippet: "Nearly half of the gluten-induced gene expression changes in CeD were
      associated with the epithelial interferon-γ response."
    explanation: Demonstrates that IFN-gamma signaling drives a major portion of
      the transcriptional changes underlying epithelial damage in celiac
      disease.
  - reference: PMID:15357947
    supports: SUPPORT
    snippet: "under conditions of dysregulated IL15 expression in vivo in patients
      with celiac disease and in vitro in healthy individuals, multiple steps of the
      NKG2D/DAP10 signaling pathway leading to ERK and JNK activation are coordinately
      primed to activate direct cytolytic function independent of TCR specificity
      in effector CD8 T cells"
    explanation: Shows how IL-15 converts intraepithelial CD8+ T cells into
      cytotoxic lymphokine-activated killer cells via NKG2D signaling, mediating
      epithelial damage.
  - reference: PMID:24942692
    supports: SUPPORT
    snippet: "the upregulation of IL-15 expression in the intestinal mucosa has become
      a hallmark of the disease"
    explanation: Identifies IL-15 upregulation as a defining feature of celiac
      disease that drives intraepithelial lymphocyte expansion and epithelial
      injury.
  - reference: PMID:38914866
    supports: SUPPORT
    snippet: "ZED1227 treatment preserved transcriptome signatures associated with
      mucosal morphology, inflammation, cell differentiation and nutrient absorption
      to the level of the gluten-free diet group."
    explanation: Provides interventional evidence that blocking TG2-mediated T
      cell activation prevents the downstream epithelial damage, villous
      atrophy, and malabsorption.
- name: Autoantibody Production
  description: >
    B cells produce antibodies against tTG (anti-tTG IgA) and
    deamidated gliadin peptides (anti-DGP). These serve as diagnostic
    markers and may contribute to pathology.
  cell_types:
  - preferred_term: Plasma Cell
    term:
      id: CL:0000786
      label: plasma cell
  evidence:
  - reference: PMID:39273359
    supports: NO_EVIDENCE
    snippet: "Celiac disease (CD) is an immune-mediated enteropathy triggered by the
      ingestion of proline- and glutamine-rich proteins, widely termed \"gluten\"\
      , in genetically susceptible individuals. CD induces an altered immune response
      that leads to chronic inflammation and duodenal mucosal damage."
    explanation: Describes the immune-mediated nature of celiac disease, which
      includes both cellular and humoral (antibody) responses to gluten
      antigens.
- name: Barrier Dysfunction
  description: >
    Increased intestinal permeability allows greater gluten peptide
    translocation. Zonulin upregulation disrupts tight junctions.
  evidence:
  - reference: PMID:38914866
    supports: PARTIAL
    snippet: "ZED1227 treatment preserved transcriptome signatures associated with
      mucosal morphology, inflammation, cell differentiation and nutrient absorption
      to the level of the gluten-free diet group."
    explanation: Blocking TG2 prevents gluten-induced disruption of epithelial
      barrier integrity and differentiation programs, indicating barrier
      dysfunction is downstream of adaptive immune activation.
phenotypes:
- name: Chronic Diarrhea
  category: Gastrointestinal
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Chronic Diarrhea
    term:
      id: HP:0002028
      label: Chronic diarrhea
  evidence:
  - reference: PMID:39273359
    supports: PARTIAL
    snippet: "CD induces an altered immune response that leads to chronic inflammation
      and duodenal mucosal damage."
    explanation: Chronic inflammation and mucosal damage from immune response to
      gluten leads to malabsorption and chronic diarrhea as a cardinal symptom.
- name: Abdominal Pain
  category: Gastrointestinal
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Abdominal Pain
    term:
      id: HP:0002027
      label: Abdominal pain
- name: Bloating
  category: Gastrointestinal
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Abdominal Distention
    term:
      id: HP:0003270
      label: Abdominal distention
- name: Weight Loss
  category: Systemic
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Weight Loss
    term:
      id: HP:0001824
      label: Weight loss
  evidence:
  - reference: PMID:38914866
    supports: PARTIAL
    snippet: "ZED1227 treatment preserved transcriptome signatures associated with
      mucosal morphology, inflammation, cell differentiation and nutrient absorption
      to the level of the gluten-free diet group."
    explanation: Weight loss results from impaired nutrient absorption due to
      villous atrophy and loss of epithelial cell differentiation and absorptive
      capacity.
- name: Iron Deficiency Anemia
  category: Hematologic
  frequency: FREQUENT
  notes: From malabsorption
  phenotype_term:
    preferred_term: Anemia
    term:
      id: HP:0001903
      label: Anemia
  evidence:
  - reference: PMID:38914866
    supports: PARTIAL
    snippet: "ZED1227 treatment preserved transcriptome signatures associated with
      mucosal morphology, inflammation, cell differentiation and nutrient absorption
      to the level of the gluten-free diet group."
    explanation: Anemia results from malabsorption of iron and other nutrients
      due to villous atrophy and impaired epithelial absorptive function in
      damaged small intestine.
- name: Fatigue
  category: Systemic
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Fatigue
    term:
      id: HP:0012378
      label: Fatigue
- name: Dermatitis Herpetiformis
  category: Dermatological
  frequency: OCCASIONAL
  notes: Skin manifestation of celiac
  phenotype_term:
    preferred_term: Skin Rash
    term:
      id: HP:0000988
      label: Skin rash
- name: Osteoporosis
  category: Musculoskeletal
  frequency: OCCASIONAL
  notes: From calcium/vitamin D malabsorption
  phenotype_term:
    preferred_term: Reduced Bone Density
    term:
      id: HP:0004349
      label: Reduced bone mineral density
biochemical:
- name: Anti-tTG IgA
  presence: Elevated
  context: Primary diagnostic marker
- name: Anti-Endomysial Antibodies
  presence: Elevated
  context: Highly specific
- name: Anti-DGP Antibodies
  presence: Elevated
  context: Useful when IgA deficient
- name: Total IgA
  presence: Variable
  context: IgA deficiency common in celiac
genetic:
- name: HLA-DQ2
  association: Risk Factor
  notes: Present in ~95% of patients
- name: HLA-DQ8
  association: Risk Factor
  notes: Most remaining patients
- name: IL2
  association: Risk Factor
- name: IL21
  association: Risk Factor
- name: BACH2
  association: GWAS
  notes: Transcription factor regulating Treg/effector T cell balance and B cell
    class switching
- name: TNFAIP3
  association: GWAS
  notes: Encodes A20, a ubiquitin-editing enzyme that negatively regulates NF-kB
    signaling
- name: CD28
  association: GWAS
  notes: T cell co-stimulatory receptor required for T cell activation
- name: EGR2
  association: GWAS
  notes: Transcription factor involved in T cell anergy and peripheral tolerance
- name: ETS1
  association: GWAS
  notes: Transcription factor regulating T and B cell development and immune
    cell differentiation
- name: IRF4
  association: GWAS
  notes: Transcription factor essential for Th17 and Th2 cell differentiation
    and plasma cell development
- name: SMAD3
  association: GWAS
  notes: TGF-beta signaling mediator regulating T cell differentiation and
    immune tolerance
- name: PTPN22
  association: GWAS
  notes: Protein tyrosine phosphatase modulating T cell receptor signaling
    threshold
environmental:
- name: Gluten Exposure
  notes: Required trigger
- name: Early Gluten Introduction
  notes: Timing may affect risk
- name: Gastrointestinal Infections
  notes: May trigger onset
- name: Gut Microbiome
  notes: May modulate risk
treatments:
- name: Gluten-Free Diet
  description: Lifelong strict gluten avoidance is the only effective treatment.
- name: Nutritional Supplementation
  description: Iron, calcium, vitamin D, B12 as needed.
- name: Monitoring
  description: Regular serology and bone density monitoring.
- name: Corticosteroids
  description: For refractory celiac disease.
- name: Dietitian Counseling
  description: Essential for dietary compliance.
classifications:
  harrisons_chapter:
  - classification_value: digestive system disorder
  - classification_value: autoimmune disease
datasets:
references:
- reference: DOI:10.1038/s41590-024-01867-0
  title: Transcriptomic analysis of intestine following administration of a
    transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in
    celiac disease
  findings: []
- reference: DOI:10.1136/bmj-2024-081353
  title: Advances in the pathophysiology, diagnosis, and management of celiac
    disease
  findings: []
- reference: DOI:10.20944/preprints202504.1947.v1
  title: Intraepithelial Lymphocytes and LAIR1 Expression in Celiac Disease
  findings: []
- reference: DOI:10.3390/ijms25179412
  title: 'Expression of MicroRNAs in Adults with Celiac Disease: A Narrative Review'
  findings: []